about
The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cellsPTTG and PBF repress the human sodium iodide symporterExpression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptakeNF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.Pituitary tumor-transforming gene and its binding factor in endocrine cancer.The pituitary tumor transforming gene in thyroid cancer.Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.Regulation of pituitary tumor transforming gene (PTTG) expression and phosphorylation in thyroid cells.Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumorsMonocarboxylate transporter 8 in neuronal cell growth.Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity.Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.LPIN2 Is Associated With Type 2 Diabetes, Glucose Metabolism, and Body CompositionPTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck CancerTargeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine UptakeDimerization of the Sodium/Iodide Symporter
P50
Q24336227-865FF577-653B-4D66-B0DD-1F908D2DD810Q28288008-6FDDFFC7-3C57-4E1C-BB12-88D1038C8A8EQ28308098-C0B0B5BE-1D53-4BC2-AF61-47D9C3A0689FQ36273267-590C2A14-AF48-4817-AACC-B6767C23937CQ37815569-6243505F-2B5E-489F-BAB6-6854186981F8Q38004366-BCFA9726-EF83-4E0E-845E-14E82ACA8F3CQ38502679-F134D0C5-34CA-4AC8-A39A-9FFC96CB1489Q38693927-183B45F3-2ECD-4C20-B7B3-0C4B4470349EQ38747716-329C77BB-3FCA-407C-9C72-C4A26D8BAADFQ38786067-15774E4E-2F5D-4D71-8A74-4640968F04AAQ38939335-1A07ED35-B0AA-4251-B09E-B2C27D3CA638Q39124079-BDC79371-F6CB-42BB-912B-1B2DE1C7C5D0Q39151345-7CE97502-5D46-4174-9E0C-75AB23C033E3Q39913872-476949B7-5BB5-49F4-9408-FBC011EBE50AQ40214509-EB0AA4E5-BB11-44BC-A753-ACA0324EA506Q50227566-57E4E502-DD29-41BC-8722-E25A34FB9658Q57309159-280479E8-1EC3-4A2B-A664-1FE4F045E2A8Q57462007-1519127B-0F04-4641-9631-50CB17EB94D5Q91044105-A881E0A5-907C-4AF1-B297-97298AF3E6C7Q91919274-F48F7A57-B3AB-41BC-BC38-E95B1D28C5B4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vicki E Smith
@ast
Vicki E Smith
@en
Vicki E Smith
@es
Vicki E Smith
@nl
Vicki E Smith
@sl
type
label
Vicki E Smith
@ast
Vicki E Smith
@en
Vicki E Smith
@es
Vicki E Smith
@nl
Vicki E Smith
@sl
altLabel
Vicki Smith
@en
prefLabel
Vicki E Smith
@ast
Vicki E Smith
@en
Vicki E Smith
@es
Vicki E Smith
@nl
Vicki E Smith
@sl
P1053
F-6972-2010
P106
P21
P31
P3829
P496
0000-0003-0757-7198